Omeprazolo Aristo Pharma (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Aristo Pharma, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazolo Aristo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazolo Aristo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

- Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prevention: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or vomiting: transient gastrointestinal upset. - Abdominal pain or flatulence: mild discomfort. - Constipation: occasional bowel habit changes. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Liver enzyme elevations: signs of hepatic dysfunction.

Before starting Omeprazolo Aristo Pharma, consider the following precautions:

- Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: use with caution in patients with liver disease. - Review long‑term use: monitor for bone density loss and magnesium levels. - Pregnancy and lactation: discuss risks and benefits with a healthcare professional. - Drug interactions: check concomitant medications for potential interactions. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir and other protease inhibitors: markedly decreased absorption, compromising antiviral efficacy. - Warfarin: enhanced anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels, requiring dose adjustment. - Methotrexate: elevated concentrations, especially at high doses. - Phenytoin: reduced plasma levels, potentially decreasing seizure control.